ABSTRACT. Peroxisomes containing fibrillar structures were induced after 1 week withdrawal of bezafibrate, a peroxisome proliferator. In this report, the relation between the duration of bezafibrate treatment and the induction of abnormal peroxisomes in rat hepatocytes was studied morphometrically. The abnormal peroxisomes did not appear during 3 to 90 days of treatment with bezafibrate, but they appeared after 1 week withdrawal of it. The number and frequency of abnormal peroxisomes were prominent in 3, 7, and 14 days of treatment followed by 1 week of withdrawal of bezafibrate. It was evident that the frequency of abnormal peroxisomes decreased with 30-90 days administration of bezafibrate. This means that long-term (30-90 days) treatment with bezafibrate suppresses the induction of abnormal peroxisomes. -KEY WORDS: abnormal peroxisome, bezafibrate, morphometry.
analyzer (Rise, Sendai, Japan). The morphometric data was statistically analyzed with Student's t-test or Welch's t-test after preliminary analysis by the F-test for equal variance (p<0.05).
Morphometric analysis of changes of peroxisomes in rat hepatocytes after 3 to 90 days treatment followed by 1 week withdrawal of bezafibrate (Table 1 ) revealed a suppressive effect of long-term (30-90 days) administration of bezafibrate over the induction of abnormal peroxisomes. After 3, 7, and 14 days of administration followed by 1 week of withdrawal of bezafibrate, 31 to 33% of peroxisomes contained fibrillar structures (Fig. 1) . The number and frequency of abnormal peroxisomes began to decrease with 30 days administration of bezafibrate. In 90 days treatment followed by 1 week withdrawal, the number of abnormal peroxisomes was approximately half of those of the 3, 7, and 14 days' level.
Peroxisome proliferators cause remarkable hepatomegaly and increase in number and enzyme activity of peroxisomes [2, 9, 10, 12, 21] . Appearance of abnormal peroxisomes containing fibrillar structures with administration of peroxisome proliferators has been reported by several authors including us [3, 5, 11, 13, 18, 19] . Fahimi et al. [2] reported that abnormal peroxisomes did not appear in rat hepatocytes with 1 week administration of bezafibrate but they appeared after 2 years administration of the drug. However, these changes induced by peroxisomes proliferators recover to normal state after withdrawal of them [3, 15, 16] . In our previous report [6] , both the number and area of peroxisomes per unit cytoplasmic area recovered to control levels in 2 weeks after the withdrawal of bezafibrate. It was interesting that abnormal peroxisomes began to appear even in the course of suppression of peroxisomal proliferation with withdrawal of bezafibrate. We also noticed that bezafibrate administration of more than 30 days suppressed the proliferation of peroxisomes [7] . In search for the mechanism to reduce proliferated peroxisomes to normal level in comparatively short period of time [12] , we noticed that, as mentioned above, both long-term (30 to 90 days) administration of bezafibrate and 1 week Hepatic peroxisomes are proliferated with a variety of hypolipidemic drugs such as clofibrate and bezafibrate [1, 2, 17, 18] . Some of these drugs cause the fibrillar inclusion in the matrix of rat hepatic peroxisomes [3, 5, 11, 13, 18, 19] . These changes recover to normal state after withdrawal of the drugs [3, 15, 16] . We observed that abnormal peroxisomes appeared after 1 week of withdrawal of bezafibrate [6] . We also found that proliferated peroxisomes began to decrease after 30 days of treatment with bezafibrate [7] . Further to those previous findings, this report is a morphometric analysis of the combined effects of the longterm (30 and 90 days) administration and 1 week withdrawal of bezafibrate.
A total of 51 male Wistar rats (body weight 160-180 g, aged 6-7 week old) were used for this experiment. Three to five in each group were fed on a laboratory diet (CE-2, Clea Japan Inc., Tokyo, Japan) as the control group or a diet containing 0.5% bezafibrate (Kissei Pharmaceutical Co., Matsumoto, Japan) as the experimental group, for 3, 7, 14, 30, or 90 days. The animals were then transferred to control diet for 1 week. The rats in each group were sacrificed under anesthesia with sodium pentobarbital (50 mg/kg). The liver was immediately removed and the small pieces of liver tissue were fixed for 3 hr in a cold 2% glutaraldehyde in 0.1 M cacodylate buffer at pH 7.4. After rinse with cacodylate buffer containing 5% sucrose, the specimens were postfixed with a cold 2% osmium tetroxide in the same buffer for 2 hr, dehydrated with a cold ethanol series, and embedded in Poly/Bed 812 (Polysciences, Warrington, PA). Ultrathin sections stained with uranyl acetate and lead citrate were observed with a transmission electron microscope (Hitachi H-700) at 75 kV.
The ultrathin sections of three to five blocks from each liver were analyzed. Three to five cells per each section were photographed at random at × 9,000 and were further photographically enlarged to a final magnification, × 26,000. A total of 30 photomicrographs taken from each animal were morphometrically analyzed. The number and area of peroxisomes per unit cytoplasmic area and the area of peroxisome were measured with a computer-aided pattern degenerative phase in which excess of certain protein precipitates as scroll or short fibrillar form, the withdrawal of the drug, the loss of stimulation, could cause abnormal peroxisomes. The long-term administration of bezafibrate, on the other hand, would also reduce stimulative effects due to adaptive response of rats for the long and repeated stimulation.
Only autophagic mechanism has been postulated so far for the degradation of proliferated peroxisomes [4, 8, 14, 20, 22] . The suppressive effects over the proliferated peroxisomes with combination of the long-term (30-90 days) administration and the 1 week withdrawal of bezafibrate described in this report will be an alternative mechanism for the degradation of proliferated peroxisomes, though it requires further investigations.
